Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype-Positive.
Anna Isotta CastriniEystein SkjølsvikMette E EstensenVibeke M AlmaasHelge SkulstadErik LyseggenThor EdvardsenØyvind H LieKermshlise C I PicardNeal K LakdawalaKristina Hermann HaugaaPublished in: Journal of the American Heart Association (2022)
Background We aimed to assess the association between number of pregnancies and long-term progression of cardiac dysfunction, arrhythmias, and event-free survival in women with pathogenic or likely pathogenic variants of gene encoding for Lamin A/C proteins ( LMNA+). Methods and Results We retrospectively included consecutive women with LMNA+ and recorded pregnancy data. We collected echocardiographic data, occurrence of atrial fibrillation, atrioventricular block, sustained ventricular arrhythmias, and implantation of cardiac electronic devices (implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator). We analyzed retrospectively complications during pregnancy and the peripartum period. We included 89 women with LMNA+ (28% probands, age 41±16 years), of which 60 had experienced pregnancy. Follow-up time was 5 [interquartile range, 3-9] years. We analyzed 452 repeated echocardiographic examinations. Number of pregnancies was not associated with increased long-term risk of atrial fibrillation, atrioventricular block, sustained ventricular arrhythmias, or implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator implantation. Women with previous pregnancy and nulliparous women had a similar annual deterioration of left ventricular ejection fraction (-0.5/year versus -0.3/year, P =0.37) and similar increase of left ventricular end-diastolic diameter (0.1/year versus 0.2/year, P =0.09). Number of pregnancies did not decrease survival free from death, left ventricular assist device, or need for cardiac transplantation. Arrhythmias occurred during 9% of pregnancies. No increase in maternal and fetal complications was observed. Conclusions In our cohort of women with LMNA+, pregnancy did not seem associated with long-term adverse disease progression or event-free survival. Likewise, women with LMNA+ generally well-tolerated pregnancy, with a small proportion of patients experiencing arrhythmias.
Keyphrases
- left ventricular
- cardiac resynchronization therapy
- pregnancy outcomes
- preterm birth
- left atrial
- ejection fraction
- heart failure
- free survival
- aortic stenosis
- hypertrophic cardiomyopathy
- mitral valve
- pregnant women
- acute myocardial infarction
- atrial fibrillation
- muscular dystrophy
- catheter ablation
- gestational age
- congenital heart disease
- electronic health record
- risk factors
- machine learning
- risk assessment
- oxidative stress
- genome wide
- type diabetes
- gene expression
- end stage renal disease
- emergency department
- prognostic factors
- polycystic ovary syndrome
- physical activity
- left ventricular assist device
- big data
- coronary artery disease
- drug induced
- copy number
- skeletal muscle
- venous thromboembolism
- pulmonary hypertension
- stem cells
- direct oral anticoagulants